Apertura Gene Therapy agrees manufacturing collaboration with Viralgen

Humacyte submits Israel MAA for Symvess arterial trauma repair

Sentynl Therapeutics and PRG S&T enter licensing agreement for potential HGPS treatment

ONL Therapeutics reports start of European Phase 2 trial of xelafaslatide for GA associated with dry AMD

NeuroSense Therapeutics reports Phase 2b trial results of PrimeC in ALS

Avacta opens Phase 1 trial for AVA6103 cancer therapy in US

Imfinzi approved in EU for perioperative treatment of early gastric and gastroesophageal cancers

LynxKite Technologies expands Biophytis collaboration

BioDlink named 'Emerging CDMO of the Year' at Asia-Pacific Biopharma Excellence Awards

Vimgreen Pharmaceuticals receives IND clearance for VG081821 in China

Emerald Clinical Trials honoured with 2026 Asia Pacific Biopharma Excellence Award

Inimmune reports dosing of first patient in Phase 2 allergen challenge chamber trial of INI-2004

WuXi Biologics wins at 2026 Asia-Pacific Biopharma Excellence Awards for leadership in bioprocessing, manufacturing excellence, and digital innovation

Precision for Medicine opens new Japan office

Gesynta Pharma doses first patient in vipoglanstat Phase 2 clinical proof-of-concept trial